Cited by 232

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Multiple, diverse senile plaque–associated proteins are ligands of an apolipoprotein e receptor, the α2‐macroglobulin receptor/low‐density‐lipoprotein receptor—related protein

Rebeck, G. William, Harr, Steven D., Hyman, Bradley T., Strickland, Dudley K.·1995·Annals of Neurology

Abstract

Both apolipoprotein E and its receptor, the low‐density‐lipoprotein receptor‐related protein (LRP), are associated with senile plaques in Alzheimer's disease. We examined the relationship of other LRP‐related molecules to senile plaques. LRP is a multifunctional receptor that blinds and rapidly internalizes at least seven ligands: apolipoprotein E, activated α 2‐macroglobulin, tissue and urokinase‐type plasminogen activators, plasminogen activator inhibitor‐1, lipoprotein lipase, and lactoferrin. Using immunohistochemistry, we showed that all of these ligands, representing a diverse group of otherwise apparently unrelated proteins, accumulate on senile plaques. We also studied expression of the receptor‐associated protein, a physiological inhibitor of LRP, in the hippocampal formation from normal subjects and Alzheimer's disease patients. Receptor‐associated protein colocalizes with LRP on neuronal soma, but not on neuronal processes or reactive astrocytes. It is not present on senile plaques. These results suggest that senile plaque‐associated LRP can bind its ligands, but clearance of these compounds may be impaired in the vicinity of senile plaques.

Overview

Integrity signals

Registry

Crossref · 10.1002/ana.410370212

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In senile plaques, LRP1 ligands co-deposit with Aβ, indicating a loss of LRP1 function in AD.

    “In senile plaques, LRP1 ligands, like apoE, urokinase-type plasminogen activator, tissue plasminogen activator, and lactoferrin, co-deposit with Aβ, all together indicating a loss of LRP1 function in AD (14).”
  • Immunoreactivity for LRP and ligands including apoE and α2-macroglobulin is found associated with senile plaques.

    “Fourth, immunoreactivity for LRP and a number of its ligands including apoE and ␣ 2 -macroglobulin is found associated with senile plaques (30).”
  • Activated astrocytes used in the experiments express both LDLR and LRP by immunostaining.

    “By immunostaining, these activated astrocytes express both the LDLR and LRP (data not shown), consistent with the previous observations summarized above that these are the two primary members of the LDLR family that are expressed by activated astrocytes (4 -7, 29 -31).”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
  2. 10.1126/science.3810169 · DOI
  3. 10.1073/pnas.84.19.6953 · DOI
  4. 10.1016/0022-2836(91)90881-6 · DOI
  5. 10.1073/pnas.90.5.2092 · DOI · Paper page
  6. 10.1111/j.1750-3639.1991.tb00666.x · DOI
  7. 10.1006/bbrc.1993.1663 · DOI
  8. 10.1016/0014-5793(91)80737-N · DOI · Paper page
  9. 10.1016/0197-4580(93)90006-W · DOI
  10. 10.1016/0092-8674(88)90462-X · DOI
  11. 10.1016/0006-8993(91)91092-F · DOI · Paper page
  12. 10.1016/0304-3940(92)90444-C · DOI · Paper page
  13. 10.1016/0896-6273(93)90070-8 · DOI · Paper page
  14. 10.1073/pnas.90.20.9649 · DOI · Paper page
  15. Kawamata T., 1993, Lactotransferrin immunocytochemistry in Alzheimer and normal human brain, Am J Pathol, 142, 1574
  16. Snow AD, 1988, The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease, Am J Pathol, 133, 456
  17. 10.1073/pnas.90.5.1977 · DOI · Paper page
  18. 10.1212/WNL.43.8.1467 · DOI · Paper page
  19. 10.1016/0140-6736(93)91705-Q · DOI · Paper page
  20. 10.1016/0304-3940(94)91074-X · DOI · Paper page
  21. 10.1126/science.3283935 · DOI · Paper page
  22. Strittmatter WJ, 1993, Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform‐specific effects and implications for late‐onset Alzheimer disease, Proc Natl Acad Sci USA, 90, 8098, 10.1073/pnas.90.17.8098 · DOI · Paper page
  23. 10.1016/S0021-9258(18)47945-8 · DOI · Paper page
  24. 10.1073/pnas.85.24.9821 · DOI
  25. Wolf BB, 1992, Characterization and immunohistochemical localization of α2‐macroglobulin receptor (low‐density lipoprotein receptor‐related protein) in human brain, Am J Pathol, 141, 37
  26. 10.1007/BF00353892 · DOI
  27. 10.1007/BF03160029 · DOI
  28. 10.1002/j.1460-2075.1988.tb03306.x · DOI
  29. 10.1002/j.1460-2075.1990.tb08301.x · DOI
  30. 10.1073/pnas.86.15.5810 · DOI
  31. Strickland DK, 1990, Sequence identity between the α2‐macroglobulin receptor and low density lipoprotein receptor‐related protein suggests that this molecule is a multifunctional receptor, J Biol Chem, 265, 17401, 10.1016/S0021-9258(18)38172-9 · DOI · Paper page
  32. Moestrup SK, 1991, Analysis of ligand recognition by the purified α2‐macroglobulin receptor (low density lipoprotein receptor‐related protein), J Biol Chem, 266, 14011, 10.1016/S0021-9258(18)92803-6 · DOI
  33. 10.1016/S0021-9258(18)35732-6 · DOI
  34. 10.1038/341162a0 · DOI
  35. 10.1073/pnas.89.16.7427 · DOI
  36. Kounnas MZ, 1993, Low density lipoprotein receptor‐related protein/α2‐macroglobulin receptor mediates cellular uptake of pro‐urokinase, J Biol Chem, 268, 21862, 10.1016/S0021-9258(20)80620-6 · DOI
  37. Nykjaer A., 1992, Purified α2‐macroglobulin receptor/LDL receptor‐related protein bind urokinase‐plasminogen activator inhibitor type‐1 complex, J Biol Chem, 267, 14543, 10.1016/S0021-9258(18)42072-8 · DOI
  38. 10.1073/pnas.89.16.7422 · DOI
  39. 10.1016/S0021-9258(19)50384-2 · DOI · Paper page
  40. 10.1016/S0021-9258(18)54845-6 · DOI · Paper page
  41. Osmand AP, 1991, Alzheimer's disease: basic mechanisms, diagnosis and therapeutic strategies, 219
  42. 10.1097/00005072-199201000-00009 · DOI
  43. 10.1016/S0021-9258(19)36811-5 · DOI · Paper page
  44. 10.1016/0166-2236(88)90182-8 · DOI

Cited by

Sorted by citations

Metadata

Authors
Rebeck, G. W., Harr, S. D., Hyman, B. T., & Strickland, D. K.
Venue
Annals of Neurology
Publisher
Wiley
Published
1995-02
Volume
37
Issue
2
Pages
211-217
ISSN
  • 0364-5134
  • 1531-8249
Cited by
232
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review